Effectiveness of mid-regional pro-adrenomedullin, compared to other biomarkers (including lymphocyte subpopulations and immunoglobulins), as a prognostic biomarker in COVID-19 critically ill patients: New evidence from a 15-month observational prospective study

BACKGROUND: Mid-regional pro-adrenomedullin (MR-proADM), an endothelium-related peptide, is a predictor of death and multi-organ failure in respiratory infections and sepsis and seems to be effective in identifying COVID-19 severe forms. The study aims to evaluate the effectiveness of MR-proADM in c...

Descripción completa

Detalles Bibliográficos
Autores principales: Montrucchio, Giorgia, Sales, Gabriele, Balzani, Eleonora, Lombardo, Davide, Giaccone, Alice, Cantù, Giulia, D'Antonio, Giulia, Rumbolo, Francesca, Corcione, Silvia, Simonetti, Umberto, Bonetto, Chiara, Zanierato, Marinella, Fanelli, Vito, Filippini, Claudia, Mengozzi, Giulio, Brazzi, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080079/
https://www.ncbi.nlm.nih.gov/pubmed/37035317
http://dx.doi.org/10.3389/fmed.2023.1122367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080079/
https://www.ncbi.nlm.nih.gov/pubmed/37035317
http://dx.doi.org/10.3389/fmed.2023.1122367

Ejemplares similares